Psychiatry Research: Neuroimaging
Volume 146, Issue 1 , Pages 13-20 , 30 January 2006

Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia

  • Jussi Hirvonen

      Affiliations

    • Department of Psychiatry, University of Turku, 20520, Finland
    • Turku PET Centre, University of Turku, c/o Turku University Central Hospital, 20521 Turku, Finland
    • Corresponding Author InformationCorresponding author. Department of Psychiatry and Turku PET Centre, University of Turku, Kiinamyllynkatu 4-8, 20520 Turku, Finland. Tel: +358 2 313 2884; fax: +358 2 231 8191.
    • ,
  • Theo G.M. van Erp

      Affiliations

    • Departments of Psychology, Psychiatry, and Human Genetics, University of California at Los Angeles School of Medicine, 1285 Franz Hall, Los Angeles, CA 90095-1769, USA
    • ,
  • Jukka Huttunen

      Affiliations

    • Department of Psychiatry, University of Turku, 20520, Finland
    • Turku PET Centre, University of Turku, c/o Turku University Central Hospital, 20521 Turku, Finland
    • ,
  • Kjell Någren

      Affiliations

    • Turku PET Centre, University of Turku, c/o Turku University Central Hospital, 20521 Turku, Finland
    • ,
  • Matti Huttunen

      Affiliations

    • Department of Mental Health and Alcohol Research, National Public Health Institute, Mannerheimintie 166, 00300 Helsinki, Finland
    • ,
  • Sargo Aalto

      Affiliations

    • Turku PET Centre, University of Turku, c/o Turku University Central Hospital, 20521 Turku, Finland
    • Department of Psychology, Åbo Akademi University, 20500 Turku, Finland
    • ,
  • Jouko Lönnqvist

      Affiliations

    • Department of Mental Health and Alcohol Research, National Public Health Institute, Mannerheimintie 166, 00300 Helsinki, Finland
    • ,
  • Jaakko Kaprio

      Affiliations

    • Department of Mental Health and Alcohol Research, National Public Health Institute, Mannerheimintie 166, 00300 Helsinki, Finland
    • Department of Public Health, University of Helsinki, Mannerheimintie 172, 00014 Helsinki, Finland
    • ,
  • Tyrone D. Cannon

      Affiliations

    • Departments of Psychology, Psychiatry, and Human Genetics, University of California at Los Angeles School of Medicine, 1285 Franz Hall, Los Angeles, CA 90095-1769, USA
    • ,
  • Jarmo Hietala

      Affiliations

    • Department of Psychiatry, University of Turku, 20520, Finland
    • Turku PET Centre, University of Turku, c/o Turku University Central Hospital, 20521 Turku, Finland

Received 8 August 2005 ,Revised 12 October 2005 ,Accepted 14 October 2005.

References 

  1. Abi-Dargham A, Martinez D, Mawlawi O, Simpson N, Hwang DR, Slifstein M, et al. Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility. Journal of Cerebral Blood Flow and Metabolism. 2000;20:225–243
  2. Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, et al. Prefrontal dopamine D1 receptors and working memory in schizophrenia. Journal of Neuroscience. 2002;22:3708–3719
  3. Agnati LF, Fuxe K, Benfenati F, von Euler G, Fredholm B. Intramembrane receptor–receptor interactions: integration of signal transduction pathways in the nervous system. Neurochemistry International. 1993;22:213–222
  4. Aizman O, Brismar H, Uhlén P, Zetterberg E, Levey AI, Forssberg H, et al. Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nature Neurosciece. 2000;3:226–230
  5. Brück A, Aalto S, Nurmi E, Bergman J, Rinne JO. Cortical 6-[18F]fluoro-l-dopa uptake and frontal cognitive functions in early Parkinson's disease. Neurobiology of Aging. 2005;26:891–898
  6. Burt DR, Creese I, Snyder SH. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science. 1977;196:326–328
  7. Cannon TD, Huttunen MO, Lönnqvist J, Tuulio-Henriksson A, Pirkola T, Glahn D, et al. The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. American Journal of Human Genetics. 2000;67:369–382
  8. Friston KJ, Holmes AP, Worsley KJ, Poline J-P, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping. 1995;2:189–210
  9. Gerfen CR. The neostriatal mosaic: multiple levels of compartmental organization. Trends in Neurosciences. 1992;15:133–139
  10. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJJr, et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 1990;250:1429–1432
  11. Ginovart N, Lundin A, Farde L, Halldin C, Bäckman L, Swahn C-G, et al. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain. 1997;120:503–514
  12. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand–receptor binding in PET using a simplified reference region model. Neuroimage. 1997;6:279–287
  13. Guo N, Hwang D-R, Lo E-S, Huang YY, Laruelle M, Abi-Dargham A. Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia. Neuropsychopharmacology. 2003;28:1703–1711
  14. Gurevich EV, Joyce JN. Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology. 1999;20:60–80
  15. Halldin C, Foged C, Chou Y-H, Karlsson P, Swahn G-C, Sandell J, et al. Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors. Journal of Nuclear Medicine. 1998;39:2061–2068
  16. Hess EJ, Bracha HS, Kleinman JE, Creese I. Dopamine receptor subtype imbalance in schizophrenia. Life Sciences. 1987;40:1487–1497
  17. Hietala J, Syvälahti E, Vuorio K, Räkköläinen V, Bergman J, Haaparanta M, et al. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet. 1995;346:1130–1131
  18. Hirvonen J, Någren K, Kajander J, Hietala J. Measurement of cortical dopamine D1 receptor binding with [11C]SCH 23390: a test–retest analysis. Journal of Cerebral Blood Flow and Metabolism. 2001;21:1146–1150
  19. Hirvonen J, Aalto S, Lumme V, Någren K, Kajander J, Vilkman H, et al. Measurement of striatal and thalamic dopamine D2 receptor binding with [11C]raclopride. Nuclear Medicine Communications. 2003;24:1207–1214
  20. Hirvonen J, van Erp TGM, Huttunen J, Aalto S, Någren K, Huttunen M, et al. Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Archives of General Psychiatry. 2005;62:371–378
  21. Kaprio J, Koskenvuo M. Genetic and environmental factors in complex diseases: the older Finnish twin cohort. Twin Research. 2002;5:358–365
  22. Karlsson P, Farde L, Halldin C, Sedvall G. PET study of D1 dopamine receptor binding in neuroleptic-naive patients with schizophrenia. American Journal of Psychiatry. 2002;159:761–767
  23. Kebabian JW, Calne DB. Multiple receptors for dopamine. Nature. 1979;277:93–96
  24. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4:153–158
  25. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. Journal of Cerebral Blood Flow and Metabolism. 2000;20:423–451
  26. Laruelle M. Dopamine transmission in the schizophrenic brain. In:  Hirsch SR,  Weinberger DR editor. Schizophrenia. Part Two, Biological Aspects. 1st ed.. Oxford, United Kingdom: Blackwell Publishing; 2003;p. 365–387
  27. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proceedings of the National Academy of Sciences of the United States of America. 1996;93:9235–9240
  28. Lawrence AD, Weeks RA, Brooks DJ, Andrews TC, Watkins LHA, Harding AE, et al. The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease. Brain. 1998;121:1343–1355
  29. Meyer JH, Gunn RN, Myers R, Grasby PM. Assessment of spatial normalization of PET ligand images using ligand-specific templates. Neuroimage. 1999;9:545–553
  30. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiological Reviews. 1998;78:189–225
  31. Nieoullon A. Dopamine and the regulation of cognition and attention. Progress in Neurobiology. 2002;67:53–83
  32. Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O, et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature. 1997;385:634–636
  33. Parent A, Hazrati L-N. Functional anatomy of the basal ganglia: I. The cortico-basal ganglia-thalamo-cortical loop. Brain Research Reviews. 1995;20:91–127
  34. Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, et al. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not D3 receptor binding or dopamine. Neuroscience. 1999;90:433–445
  35. Rinne JO, Laihinen A, Lönnberg P, Marjamäki P, Rinne UK. A post-mortem study on striatal dopamine receptors in Parkinson's disease. Brain Research. 1991;556:117–122
  36. Rosa-Neto P, Doudet DJ, Cumming P. Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET. Neuroimage. 2004;22:1076–1083
  37. Seeman P, Tallerico T. Link between dopamine D1 and D2 receptors in rat and human striatal tissues. Synapse. 2003;47:250–254
  38. Seeman P, Bzowej NH, Guan H-C, Bergeron C, Becker LE, Reynolds GP, et al. Human brain dopamine receptors in children and aging adults. Synapse. 1987;1:399–404
  39. Seeman P, Niznik HB, Guan H-C, Booth G, Ulpian C. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Proceedings of the National Academy of Sciences of the United States of America. 1989;86:10156–10160
  40. Seeman P, Sunahara RK, Niznik HB. Receptor–receptor link in membranes revealed by ligand competition: example for dopamine D1 and D2 receptors. Synapse. 1994;17:62–64
  41. Silvestri S, Seeman MV, Negrete J-C, Houle S, Shammi CM, Remington GJ, et al. Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology. 2000;152:174–180
  42. Surmeier DJ, Song W-J, Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. Journal of Neuroscience. 1996;16:6579–6591
  43. Turjanski N, Weeks R, Dolan R, Harding AE, Brooks DJ. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study. Brain. 1995;118:689–696
  44. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, et al. Prefrontal neurons and the genetics of schizophrenia. Biological Psychiatry. 2001;50:825–844

PII: S0925-4927(05)00173-3

doi: 10.1016/j.pscychresns.2005.10.004

Psychiatry Research: Neuroimaging
Volume 146, Issue 1 , Pages 13-20 , 30 January 2006

Article Tools

* Image Usage & Resolution